Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ligand Pharmaceuticals Incorporated (LGND)

112.36   -2.45 (-2.13%) 05-23 16:00
Open: 113.7 Pre. Close: 114.47
High: 115.79 Low: 112.55
Volume: 184,251 Market Cap: 2202M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 114.382 - 115.039 115.039 - 115.631
Low: 109.574 - 110.283 110.283 - 110.922
Close: 111.334 - 112.477 112.477 - 113.509

Technical analysis

as of: 2019-05-23 4:26:34 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 143.50     One year: 152.00
Support: Support1: 111.07    Support2: 92.41
Resistance: Resistance1: 122.86    Resistance2: 130.14
Pivot: 116.54
Moving Average: MA(5): 113.78     MA(20): 119.00
MA(100): 121.88     MA(250): 171.72
MACD: MACD(12,26): -2.90     Signal(9): -2.39
Stochastic oscillator: %K(14,3): 15.18     %D(3): 14.13
RSI: RSI(14): 37.36
52-week: High: 278.62  Low: 98.56  Change(%): -40.7
Average Vol(K): 3-Month: 46339  10-Days: 26252

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
LGND has closed above bottom band by 21.2%. Bollinger Bands are 21.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 20 May 2019 15:15:13 Z
Ligand Grants Preclinical Candidate Rights to UK-based Firm

Mon, 20 May 2019 15:06:05 Z
Analysts See 13% Upside For The Holdings of MDY

Sun, 19 May 2019 22:07:40 Z
Validea's Top Five Healthcare Stocks Based On Peter Lynch - 5/19/2019

Sun, 19 May 2019 22:06:33 Z
Validea's Top Five Healthcare Stocks Based On David Dreman - 5/19/2019

Fri, 10 May 2019 15:55:38 Z
XBI, LGND, SAGE, GBT: Large Inflows Detected at ETF

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 19.60
Shares Float (M) 18.12
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 6.550
EPS Est. Current Year 2.950
EPS Est. Next Year 3.870
EPS Est. Next Quarter 1.090
Forward EPS 5.969
Book Value (p.s.) 2.110
PEG Ratio 1.08
Profit Margin
Operating Margin 58.81
Return on Assets (ttm) 58.8
Return on Equity (ttm) 100.7
Qtrly Rev. Growth -22.6
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 1371.60
Operating Cash Flow (M) 178.56
Levered Free Cash Flow (M) 1070.00

Stock Valuations

P/E 17.15
P/E Growth Ratio -0.02
P/BV 53.25
P/S 193349968.00
P/CF 12.33

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 2010-07-02
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.